IDEX Corporation is a diversified industrial company focused on engineered products and technologies in niche markets such as fluidics, health sciences, and fire & safety. It generates significant revenue through high-margin product sales, including precision pumps and metering systems, and reported around $3.2 billion in fiscal 2022. Under CEO Andrew Silverstein, IDEX has built a strong competitive position through both organic growth and strategic acquisitions. The company is actively pursuing expansion and technological innovation to drive future growth.
Financial Statements
In thousands, USD
FY 2025
FY 2024
FY 2023
FY 2022
Total Revenues
3,457,500
3,268,800
3,273,900
3,181,900
Cost of Sales
1,918,700
1,823,600
1,827,000
1,755,000
Gross Profit
1,538,800
1,445,200
1,446,900
1,426,900
Selling, General & Administrative Expenses
818,800
758,700
703,500
652,700
Other Operating Expenses
20,700
9,300
10,900
22,800
Operating Profit
699,300
677,200
732,500
751,400
Interest Expense
(64,400)
(44,500)
(51,700)
(40,700)
Non-Operating Income
2,300
1,400
89,900
30,900
Total Non-Operating Income
(62,100)
(43,100)
38,200
(9,800)
Income Before Provision for Income Taxes
632,600
639,300
760,300
749,400
Provision for Income Taxes
150,100
134,700
164,700
162,700
Consolidated Net Income
482,500
504,600
595,600
586,700
Net Income Attributable to Minority Interests and Other
(700)
(400)
(500)
(200)
Net Income Attributable to Common Shareholders
483,200
505,000
596,100
586,900
Basic EPS
6.41
6.66
7.87
7.74
Diluted EPS
6.41
6.64
7.85
7.71
Basic Weighted Average Shares Outstanding
75,300
75,700
75,600
75,700
Diluted Weighted Average Shares Outstanding
75,300
75,900
75,900
76,000
Shares Outstanding
74,600
75,900
75,729
75,614
FY 2025
FY 2024
FY 2023
FY 2022
Cash and Cash Equivalents
580,000
620,800
534,300
430,200
Total Cash and Cash Equivalents
580,000
620,800
534,300
430,200
Accounts Receivable
521,700
465,900
427,800
442,800
Total Trade Receivables
521,700
465,900
427,800
442,800
Inventories
479,400
429,700
420,800
470,900
Other Current Assets
62,100
76,300
63,400
55,400
Total Current Assets
1,643,200
1,592,700
1,446,300
1,399,300
Net Property, Plant & Equipment
468,000
460,400
430,300
382,100
Net Intangible Assets
1,247,400
1,284,800
1,011,800
947,800
Goodwill
3,414,500
3,251,700
2,838,300
2,638,100
Other Long-Term Assets
153,900
155,700
138,500
144,600
Total Assets
6,927,000
6,745,300
5,865,200
5,511,900
Accounts Payable
224,700
197,800
179,700
208,900
Accrued Expenses
297,000
278,700
271,500
289,100
Current Portion of Long-Term Debt
700
100,700
600
—
Other Current Liabilities
53,000
52,500
48,500
45,600
Total Current Liabilities
575,400
629,700
500,300
543,600
Long-Term Debt
1,820,100
1,859,500
1,325,100
1,468,700
Other Long-Term Liabilities
505,300
462,000
498,600
460,000
Total Long-Term Liabilities
2,325,400
2,321,500
1,823,700
1,928,700
Total Liabilities
2,900,800
2,951,200
2,324,000
2,472,300
Common Stock
900
900
900
900
Treasury Stock
(1,423,200)
(1,170,300)
(1,187,000)
(1,184,300)
Additional Paid-in Capital
892,100
864,800
839,000
817,200
Accumulated Other Comprehensive Income
57,600
(130,900)
(45,800)
(126,200)
Retained Earnings
4,500,100
4,230,200
3,934,300
3,531,700
Total Common Shareholders' Equity
4,027,500
3,794,700
3,541,400
3,039,300
Minority Interests and Other
(1,300)
(600)
(200)
300
Total Shareholders' Equity
4,026,200
3,794,100
3,541,200
3,039,600
Total Liabilities and Shareholders' Equity
6,927,000
6,745,300
5,865,200
5,511,900
FY 2025
FY 2024
FY 2023
FY 2022
Net Income
482,500
504,600
595,600
586,700
Depreciation & Amortization
206,500
175,600
152,100
119,700
Share-Based Compensation Expense
27,300
25,800
21,800
21,600
Other Adjustments
21,200
(23,300)
(98,600)
(35,900)
Changes in Trade Receivables
(41,200)
(16,900)
20,500
(71,700)
Changes in Inventories
(34,200)
17,600
66,200
(72,400)
Changes in Accounts Payable
15,200
8,900
(25,300)
17,600
Changes in Accrued Expenses
1,800
(8,600)
(34,800)
16,600
Changes in Unearned Revenue
2,700
(17,900)
12,700
(25,000)
Changes in Other Operating Activities
6,300
2,300
(1,200)
200
Cash from Operating Activities
680,400
668,100
716,700
557,400
Capital Expenditure
(63,600)
(65,100)
(89,900)
(68,000)
Purchases of Investments
—
—
(29,000)
—
Proceeds from Sale of Investments
—
4,500
24,800
39,700
Payments for Business Acquisitions
(76,200)
(984,500)
(311,800)
(945,600)
Proceeds from Business Divestments
—
45,100
118,600
49,400
Other Investing Activities
2,200
(6,500)
3,500
7,300
Cash from Investing Activities
(137,600)
(1,006,500)
(283,800)
(917,200)
Issuance of Short-Term Debt
252,000
279,300
—
210,400
Repayments of Short-Term Debt
(322,900)
(69,100)
—
(135,000)
Net Issuance / (Repayments) of Short-Term Debt
(70,900)
210,200
—
75,400
Issuance of Long-Term Debt
—
496,700
100,000
200,000
Repayments of Long-Term Debt
(100,000)
(50,000)
(250,000)
—
Net Issuance / (Repayments) of Long-Term Debt
(100,000)
446,700
(150,000)
200,000
Issuance of Common Shares
(500)
16,700
21,500
14,100
Repurchases of Common Shares
(247,800)
—
(24,200)
(148,100)
Net Issuance / (Repurchases) of Common Shares
(248,300)
16,700
(2,700)
(134,000)
Common Share Dividends Paid
(212,600)
(205,300)
(190,700)
(177,400)
Other Financing Activities
(800)
(2,400)
(1,300)
(1,800)
Cash from Financing Activities
(632,600)
465,900
(344,700)
(37,800)
Effect of Exchange Rate Changes on Cash and Cash Equivalents
36,800
(22,900)
15,900
(27,600)
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash